News2022-09-12T16:29:50-05:00
January 17th, 2025|

DOJ Files Complaint in Intervention in Baron & Budd Whistleblower Lawsuit Against Walgreens

Walgreens allegedly failed in its duties under the Controlled Substances Act by filling medically unnecessary prescriptions and ignoring red flags. Washington, D.C. -- Yesterday, the United States Department of Justice (DOJ) filed a complaint in intervention in four separate whistleblower lawsuits brought by whistleblowers under the Controlled Substances Act (CSA) [...]

Baron & Budd Represents Whistleblower in DOJ’s $2.8 Million Settlement With Hensel Phelps Involving Small Business Subcontracting Fraud

May 13th, 2022|

Baron & Budd’s client provided the critical inside information to the DOJ that resulted in this small business fraud settlement May 13, 2022 10:07 AM [...]

U.S. Department of Justice Recovers More Than $5.6 Billion From False Claims Act Cases in 2021

March 3rd, 2022|

The U.S. Department of Justice (DOJ) recently announced that it recovered more than $5.6 billion from False Claims Act cases in fiscal year 2021—the second-highest [...]

Go to Top